1. European Directorate for the Quality oEuropean Directorate for the Quality of Medicines, European Pharmacopeia, 6th ed., Strasbourg, 2006.
2. The European Agency for the Evaluation of Medicinal Products, Human Medicine Evaluation Unit, ICH Topic Q3A, Impurities Testing Guideline: Impurities in New Drug Substances, 1995.
3. ICHQ3B(R2), Impurities in New Drug Products. In ICH Harmonized Tripartite Guideline prepared within the International Conference on the Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2006. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html .
4. ICHQ3A(R2), Impurities in New Drug Products. In ICH Harmonized Tripartite Guideline prepared within the International Conference on the Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2006. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html .
5. United States Pharmacopoeia Commission, The United States Pharmacopeia 30, Rockville, 2006.